07-03-2023 15:47
via
news.google.com
HC Wainwright Adjusts Price Target on Cara Therapeutics to $20 From $25, Keeps Buy Rating - Marketscreener.com
HC Wainwright Adjusts Price Target on Cara Therapeutics to $20 From $25, Keeps Buy Rating Marketscreener.com
Read more »